Statement of shareholders' equity - Novozymes A/S


Audited by PwC
Common stock Revaluation reserve according to the equity method Treasury stock Retained earnings Proposed dividend Total
  DKK million DKK million DKK million DKK million DKK million DKK million  
Shareholders' equity at January 1, 2010 650  408  (1,777) 6,092  358  5,731 
Net profit (912) 2,500  1,588 
Dividend:
      Dividend paid (374) (374)
      Dividend paid relating to treasury stock (1) 16  15 
      Proposed dividend, gross (520) 520    - 
      Proposed dividend relating to treasury stock 16  (16)   - 
Treasury stock:
      Sale of treasury stock 145  145 
Currency translation of investments in subsidiaries, etc. 445  445 
Value adjustment of derivatives (67) (67)
Other adjustments   504    (289)   215   
Shareholders' equity at December 31, 2010 650    - (1,632) 8,176  504  7,698 
Shareholders' equity at January 1, 2009 650  460  (1,813) 4,764  325  4,386 
Net profit (52) 1,205  1,153 
Dividend:
      Dividend paid (341) (341)
      Dividend paid relating to treasury stock (1) 16  15 
      Proposed dividend, gross (374) 374    - 
      Proposed dividend relating to treasury stock 16  (16)   - 
Treasury stock:
     Sale of treasury stock 36  36 
Currency translation of investments in subsidiaries, etc. 77  77 
Value adjustment of derivatives 120  120 
Other adjustments       285    285   
Shareholders' equity, December 31, 2009 650  408  (1,777) 6,092  358  5,731 
Reference is made to Note 20 in the consolidated financial statements concerning treasury stock and average number of shares.
My Report

0 pages added